Bain Capital Life Sciences
Venture firm
Bain Capital Life Sciences investment thesis
more INVESTOR LOGIN LOCATIONS SEARCH CLOSE Bain Capital Life Sciences About Approach Portfolio People News Contact Scroll Up to Approach Portfolio Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe. Portfolio listing as of Jan 1, 2026. Layout: Status: All All Active Former Abcuro 2023 ADARx Pharmaceuticals 2023 Affera 2021 Affinivax 2020 Aiolos Bio 2023 Alkeus Pharmaceuticals 2022 Amunix Pharmaceuticals 2021 Amylyx Pharmaceuticals 2021 Angitia 2024 Annexon Biosciences 2018 Apreo 2025 Aptinyx 2017 Arcutis Biotherapeutics 2018 Areteia Therapeutics 2022 Atea Pharmaceuticals 2020 Atsena 2025 Avistone Pharmaceuticals 2021 Beeline Medicines 2026 C4 Therapeutics 2020 Cabaletta Bio 2023 Cardu
Bain Capital Life Sciences team (18)
Partners and principals at Bain Capital Life Sciences:
- Brad Balter — sweet spot $1.5M
- Jonah Cashdan — sweet spot $1.5M
- Michael Cooney — sweet spot $1.5M
- Jennie Daisak — sweet spot $1.5M
- Nicholas Downing — sweet spot $1.5M
- Drew Field — sweet spot $1.5M
- Dylan Goldstein — sweet spot $1.5M
- Evan Greif — sweet spot $1.5M
- Andrew Hack — sweet spot $1.5M
- Adam Koppel — sweet spot $1.5M
- Benjamin Lund — sweet spot $1.5M
- Ritika Mahal — sweet spot $1.5M
- Tapan Maniar — sweet spot $1.5M
- Jeffrey Schwartz — sweet spot $1.5M
- Ricky Lijing Sun — sweet spot $1.5M
- Harris Weber — sweet spot $1.5M
- Julie Yang — sweet spot $1.5M
- Amir Zamani — sweet spot $1.5M
Bain Capital Life Sciences portfolio companies
Companies listed on Bain Capital Life Sciences's public materials include: more, INVESTOR LOGIN, LOCATIONS, Life Sciences, About, Approach, Portfolio, People, News, Scroll Up to Approach, All, Active, Former, Abcuro 2023, Abcuro, ADARx Pharmaceuticals 2023, ADARx Pharmaceuticals, Affera 2021, Affera, Affinivax 2020, Affinivax, Aiolos Bio 2023, Aiolos Bio, Alkeus Pharmaceuticals 2022, Alkeus Pharmaceuticals, Amunix Pharmaceuticals 2021, Amunix Pharmaceuticals, Amylyx Pharmaceuticals 2021, Amylyx Pharmaceuticals, Angitia 2024, Angitia, Annexon Biosciences 2018, Annexon Biosciences, Apreo 2025, Apreo, Aptinyx 2017, Aptinyx, Arcutis Biotherapeutics 2018, Arcutis Biotherapeutics, Areteia Therapeutics 2022, Areteia Therapeutics, Atea Pharmaceuticals 2020, Atea Pharmaceuticals, Atsena 2025, Atsena, Avistone Pharmaceuticals 2021, Avistone Pharmaceuticals, Beeline Medicines 2026, Beeline Medicines, C4 Therapeutics 2020, C4 Therapeutics, Cabaletta Bio 2023, Cabaletta Bio, Cardurion Pharmaceuticals 2021, Cardurion Pharmaceuticals, Cerevasc 2024, Cerevasc, Cerevel Therapeutics 2018, Cerevel Therapeutics, Cidara 2024.
Is Bain Capital Life Sciences a fit for your round?
Upload your pitch deck and see whether anyone at Bain Capital Life Sciences appears in your top matches.
Find investors for your deck